Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biohaven Ltd. (BHVN)
NYSE:BHVN
Biohaven Ltd. (BHVN) Stock Price & Analysis
73 Followers
BHVN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.45 - $28.85
Previous Close$27.92
Volume722.27K
Average Volume (3M)1.14M
Market Cap
$2.24B
Enterprise Value$1.82B
Total Cash (Recent Filing)$449.58M
Total Debt (Recent Filing)$29.76M
Price to Earnings (P/E)-4.4
Beta2.70
Next Earnings
Nov 08, 2023EPS Estimate
-$1.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.32
Shares Outstanding68,317,078
10 Day Avg. Volume1,390,316
30 Day Avg. Volume1,144,279
Standard Deviation0.51
R-Squared0.22
Alpha0.11
Financial Highlights & Ratios
Price to Book (P/B)4.23
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-6.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-13.44
Forecast
1Y Price Target
$27.20Price Target Upside-1.13% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Biohaven Ltd. News
The FlyBiohaven rises 26.6%
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BHVN FAQ
What was Biohaven Ltd.’s price range in the past 12 months?
Biohaven Ltd. lowest stock price was $9.45 and its highest was $28.85 in the past 12 months.
What is Biohaven Ltd.’s market cap?
Currently, no data Available
When is Biohaven Ltd.’s upcoming earnings report date?
Biohaven Ltd.’s upcoming earnings report date is Nov 08, 2023 which is in 21 days.
How were Biohaven Ltd.’s earnings last quarter?
Biohaven Ltd. released its earnings results on Jul 31, 2023. The company reported -$1.32 earnings per share for the quarter, missing the consensus estimate of -$1.182 by -$0.138.
Is Biohaven Ltd. overvalued?
According to Wall Street analysts Biohaven Ltd.’s price is currently Overvalued.
Does Biohaven Ltd. pay dividends?
Biohaven Ltd. does not currently pay dividends.
What is Biohaven Ltd.’s EPS estimate?
Biohaven Ltd.’s EPS estimate is -$1.34.
How many shares outstanding does Biohaven Ltd. have?
Biohaven Ltd. has 80,083,540 shares outstanding.
What happened to Biohaven Ltd.’s price movement after its last earnings report?
Biohaven Ltd. reported an EPS of -$1.32 in its last earnings report, missing expectations of -$1.182. Following the earnings report the stock price went up 4.357%.
Which hedge fund is a major shareholder of Biohaven Ltd.?
Among the largest hedge funds holding Biohaven Ltd.’s share is Farallon Capital Management, L.L.C.. It holds Biohaven Ltd.’s shares valued at 18M.
---
Biohaven Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$27.20 (-1.13% Downside)
$27.20 (-1.13% Downside)
Blogger Sentiment
Bullish
BHVN Sentiment 66%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 295.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $23.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.9%
Last 30 Days ▲ 6.0%
Last 30 Days ▲ 6.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Learn more about TipRanks Smart Score
Company Description
Biohaven Ltd.
Biohaven Ltd is a commercial-stage biopharmaceutical company with a portfolio of innovative therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including rare disorders. Biohaven's Neuroinnovation portfolio includes FDA-approved Nurtec ODT (rimegepant) for the acute and preventive treatment of migraine (EMA-approved as Vydura (rimegepant) for the acute treatment of migraine with or without aura, and prophylaxis of episodic migraine.
---
Top 5 ETFs holding BHVN
Vanguard Health Care ETF
$5.23M
Schwab U.S. Broad Market ETF
$908.38K
FlexShares Morningstar US Market Factor Tilt Index Fund
$393.43K
Vanguard U.S. Momentum Factor ETF
$156.94K
Vanguard Russell 3000 ETF
$95.82K
Up to five ETFs with an Outperform Smart Score that hold BHVN. The ETFs are listed according to market value of BHVN within the ETF
---